一个通用的I/II期剂量优化试验设计,具有多类别和多级别的结果
Yichen Yan1, Ruitao Lin2, Tianyu Guan3
1Department of Statistical and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.
Statistics in medicine
|April 11, 2025
概括
这项研究引入了一种新的临床试验设计,用于I/II期试验,整合了多级毒性和疗效数据. 新的设计准确地确定了最佳生物剂量 (OBD),即使与非单调的剂量-疗效关系.
科学领域:
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 临床试验设计的进步是由准确的观察和合理的假设驱动的.
- 最近的试验越来越多地收集多级结果,以增强分析洞察力.
- 非单调的剂量-疗效关系比传统假设更现实.
研究的目的:
- 提出一项新的I/II期临床试验设计.
- 同时处理多类毒性和有效性,具有多级结果.
- 在非单调的剂量-疗效关系下,准确确定最佳生物剂量 (OBD).
主要方法:
- 该设计整合了多类毒性和疗效数据,使用准连续概率.
- 它使用临床意义和毒性概率间隔的权重矩阵来选剂量.
- 适应剂量升级/降级的决定是基于后置剂量可取性 (效用) 的后置分布做出的.
主要成果:
- 数字模拟在多种场景中证明了强大的安全性,准确性和可靠性.
- 与现有设计进行基准测试,显示出优越的整体性能.
- 拟议的设计有效地识别OBD在非单调剂量有效性设置.
结论:
- 拟议的I/II期设计在临床试验方法学方面取得了重大进展.
- 它通过适应复杂的剂量反应关系,为剂量选择提供了更现实的,更准确的方法.
- 与当前方法相比,该设计表现出卓越的性能和稳定性.
相关概念视频
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Dose-Response Relationship: Overview
2.8K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.8K


